Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-16T05:51:45.248Z Has data issue: false hasContentIssue false
  • English
  • Français

How does psychotropic medication consent work for youth in foster care

Published online by Cambridge University Press:  23 March 2020

C. Pataki ,
C. Thompson ,
G. Crecelius ,
J. Tesoro ,
G. Polsky  and
P. Kambam
C. Pataki*
Affiliation:
David Geffen School of Medicine at UCLA, Psychiatry & Biobehavioral Science, Los Angeles, California, USA Department of Mental Health, Juvenile Court Mental Health Service, Monterey Park, California, USA
C. Thompson
Affiliation:
David Geffen School of Medicine at UCLA, Psychiatry & Biobehavioral Science, Los Angeles, California, USA Department of Mental Health, Juvenile Justice Mental Health Program, Los Angeles, California, USA
G. Crecelius
Affiliation:
Department of Mental Health, Juvenile Court Mental Health Service, Monterey Park, California, USA
J. Tesoro
Affiliation:
Department of Mental Health, Juvenile Court Mental Health Service, Monterey Park, California, USA University of Southern Californa School of Pharmacy, Pharmacy, Los Angeles, California, USA
G. Polsky
Affiliation:
Department of Mental Health, Juvenile Court Mental Health Service, Monterey Park, California, USA
P. Kambam
Affiliation:
Department of Mental Health, Juvenile Court Mental Health Service, Monterey Park, California, USA
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

It is well known that youth in foster care are at high risk for psychiatric disorders, recently reported in up to 89%, with over 55% exhibiting ADHD in one sample (Linares et al., 2013). Psychotropic medication use was reported in 59% of foster care youth within a 2-month period (Brenner et al., 2013). The psychotropic medication consent process in Los Angeles for dependent children is multidisciplinary, starting with the treating psychiatrist's written authorization request to Children's Dependency Court. Once received, it is distributed to the child's attorney, social worker, and Juvenile Court Mental Health Service (JCMHS). JCMHS reviews and provides recommendations to the judicial officer who ultimately approves, modifies, or denies consent.

Objectives

To present the steps and reasoning in the process of review, consultation, recommendations and decisions in psychotropic medication consent for dependent youth.

Aims

To provide an understanding of the multidisciplinary review process involved in determining psychotropic medication consent in foster care youth.

Method

Presentation of a timeline, forms and guidelines used in the process including the “Psychotropic Medication Authorization Form” (PMA) (Judicial Council of California, 2008).

Results

Categories of recommendations and approvals provided to the judicial officer will be presented and rationales for in-person consultations.

Conclusion

The psychotropic medication consent process for foster care youth is a complex multidisciplinary process which includes a clinically significant set of recommendations from JCMHS to the judicial officer to aid in making informed decisions regarding psychotropic medication.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
EV287
Information
European Psychiatry , Volume 33 , Issue S1: Abstracts of the 24th European Congress of Psychiatry , March 2016 , pp. S355 - S356
Copyright
Copyright © European Psychiatric Association 2016
Submit a response

Comments

No Comments have been published for this article.